Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Centre Francois Baclesse | OTHER |
Not provided
Not provided
Not provided
Not provided
Suspension laryngoscopy is realised during apnea. In effect, surgeons are in the mouth of the patient and we can't have access at the aiways.
So investigators like to use a Transnasal Humidified Rapid-Insufflation Ventilatory Exchange (THRIVE) to increase time of apnea and decrease the impact of oxygen desaturation.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Standard Allocation | No Intervention | apnea without oxygenation like usual traitement | |
| oxygenation optiflow | Experimental | optiflow oxygenation during apnea |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| optiflow | Device | we use Transnasal Humidified Rapid-Insufflation Ventilatory Exchange (thrive-optiflow) during general anesthesia for suspension laryngoscopy |
|
| Measure | Description | Time Frame |
|---|---|---|
| desaturation defined as the number of patient who presented at least one desaturation during suspension laryngoscopy | the number of patient who presented at least one desaturation during suspension laryngoscopy. An oxygen desaturation define like SpO2<96% | Two hours |
| Measure | Description | Time Frame |
|---|---|---|
| hypoxemia (decrease the number of Hypoxemia event define like SpO2<90%) | Decrease the number of Hypoxemia event define like SpO2<90% | 2 hours |
| side effect | decrease the number of side effects |
| Measure | Description | Time Frame |
|---|---|---|
| time of apnea | increase time of apnea with THRIVE | 2 hours |
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Eleonore Mulac-Vauclair | Centre Francois Baclesse | Principal Investigator |
| Pierre-Emmanuel Marsan | University Hospital, Caen | Principal Investigator |
| Kamga Herve | University Hospital, Caen | Principal Investigator |
| Boutros Mariam | University Hospital, Caen | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| CaenUH | Caen | Normandy | 14000 | France | ||
| Centre François Baclesse |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| 2 hours |
| Caen |
| 14000 |
| France |
| ID | Term |
|---|---|
| C537417 | Butyrylcholinesterase deficiency |
| D001049 | Apnea |
| D007818 | Laryngeal Diseases |
| D000013 | Congenital Abnormalities |
| ID | Term |
|---|---|
| D012120 | Respiration Disorders |
| D012140 | Respiratory Tract Diseases |
| D012818 | Signs and Symptoms, Respiratory |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D010038 | Otorhinolaryngologic Diseases |
| D009358 | Congenital, Hereditary, and Neonatal Diseases and Abnormalities |
Not provided
Not provided